Overview of the pharmacology and physiological roles of P2Y receptors

Wiley Interdisciplinary Reviews: Membrane Transport and Signaling

Volumn 1, Issue 5, 2012, Pages 581-588

  Boeynaems, Jean Marie ^a   Communi, Didier ^a   Robaye, Bernard ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; DENUFOSOL; DIQUAFOSOL; PRASUGREL; PURINERGIC P2 RECEPTOR ANTAGONIST; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y13 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; TICAGRELOR; TICLOPIDINE;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ASTHMA; ATHEROSCLEROSIS; BLEEDING; BONE MINERALIZATION; BONE TURNOVER; CYSTIC FIBROSIS; DRUG TARGETING; DRY EYE; EPITHELIUM; HYDRATION; LIPID METABOLISM; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOSIS; UPREGULATION;

EID: 84879192751     PISSN: 2190460X     EISSN: 21904618     Source Type: Journal    
DOI: 10.1002/wmts.44     Document Type: Review

References (65)

1. Drury AN, Szent-Györgyi A. The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol 1929, 68:213-237.
2. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovic M, Sharma P, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461:282-286.
3. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, Muskens F, Hoogsteden HC, Luttmann W, Ferrari D, Di Virgilio F, et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007, 13:913-919.
4. Di Virgilio F, Boeynaems J-M, Robson SC. Extracellular nucleotides as negative modulators of immunity. Curr Opin Pharmacol 2009, 9:507-513.
5. Homolya L, Steinberg TH, Boucher RC. Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelial cells. J Cell Biol 2000, 150:1349-1359.
6. McNamara N, Khong A, McKemy D, Caterina M, Boyer J, Julius D, Basbaum C. ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor. Proc Natl Acad Sci U S A 2001, 98:9086-9091.
7. 2 purinergic receptors to facilitate HIV-1 infection. J Exp Med 2011, 208:1823-1834.
8. Lazarowski ER, Shea DA, Boucher RC, Harden TK. Release of UDP-glucose as a potential extracellular signalling molecule. Mol Pharmacol 2003, 63:1190-1197.
9. +-ATPase. J Biol Chem 2003, 278:33436-33444.
10. Forsyth AM, Wan J, Owrutsky PD, Abkarian M, Stone HA. Multiscale approach to link red blood cell dynamics, shera stress viscosity and ATP release. Proc Natl Acad Sci U S A 2011, 108:10986-10991.
11. 7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J Clin Invest 2011, 121:2037-2047.
12. Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER, Armstrong AJ, Penuela S, Laird DW, Salvesen GS, et al. Pannexin 1 channels mediate "find-me" signal release and membrane permeability during apoptosis. Nature 2010, 467:863-867.
13. 2+ signals across the inner ear. Proc Natl Acad Sci U S A 2008, 105:18770-18775.
14. Beigi R, Kobatake E, Aizawa M, Dubyak GR. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol 1999, 276:C267-C278.
15. Deaglio S, Robson SC. Ectonucleotidases as regulators of purinergic signalling in thrombosis, inflammation, and immunity. Adv Pharmacol 2011, 61:301-332.
16. Burnstock G. A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L, eds. Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. New York: Raven Press; 1978, 107-118.
17. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of purinoceptor? Gen Pharmacol 1985, 16:433-440.
18. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 1993, 324:219-225.
19. Lustig KD, Shiau AK, Brake AJ, Julius D. Expression cloning of an ATP receptor from mouse neuroblasoma cells. Proc Natl Acad Sci U S A 1993, 90:5113-5117.
20. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell G. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature 1994, 371:516-519.
21. Brake AJ, Wagenbach MJ, Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 1994, 371:519-523.
22. Abbracchio MP, Burnstock G, Boeynaems J-M, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, et al. International Union of Pharmacology. Update and subclassification of the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006, 58:281-341.
23. Jacobson KA, Boeynaems J-M. P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today 2010, 15:570-578.
24. 12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci U S A 2006, 103:11069-11074.
25. 11 receptor. Biochem J 2008, 409:107-116.
26. 1 receptors in living cells. FEBS Lett 2002, 523:147-151.
27. 1 receptor. Mol Pharmacol 2004, 65:426-436.
28. 11 and SSF1 genes. J Biol Chem 2001, 276:16561-16566.
29. 2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 2004, 279:35679-35686.
30. 5 and its ligand LPA are involved in the maintenance of human hair growth. Nat Genet 2008, 40:329-334.
31. Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev 2010, 62:579-587.
32. Noguchi K, Ishii S, Shimizu T. Identification of p2y9/ GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 2003, 278:25600-25606.
33. 10 receptor as the shingosine-1-phosphate and lysophosphatidic receptor. Biochem Biophys Res Commun 2008, 371:707-712.
34. Tabata K, Baba K, Shiraishi A, Ito M, Fujita N. The orphan receptor GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun 2007, 363:861-866.
35. Sugo T, Tachimoto H, Chikatsu T, Murakami Y, Kikukawa Y, Sato S, Kikuchi K, Nagi T, Harada M, Ogi K, et al. Identification of a lysophosphatidylserine receptor on mast cells. Biochem Biophys Res Commun 2006, 341:1078-1087.
36. Mellor EA, Maekawa A, Austen KF, Boyce JA. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci U S A 2001, 98:7964-7969.
37. 6 receptors require an intact cysteinyl leukotriene synthetic and signalling system to induce survival and activation of mast cells. J Immunol 2009, 182:1129-1137.
38. Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 2006, 25:4615-4627.
39. Maekawa A, Balestrieri B, Austen KF, Kanaoka Y. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc Natl Acad Sci U S A 2009, 106:11685-11690.
40. 1 receptor-null mice. J Clin Invest 1999, 104:1731-1737.
41. 1-deficient mice. Nat Med 1999, 5:1199-1202.
42. 1 receptors. Circulation 2008, 118:754-763.
43. 3 receptors. Science 2006, 314:1792-1795.
44. 2 receptor regulates vascular cell adhesion molecule-1 (VCAM-1) membrane and soluble forms and eosinophil accumulation during lung inflammation. J Immunol 2010, 185:3702-3707.
45. - transport. J Biol Chem 1999, 274:26461-26468.
46. 2 receptor. Biochem Pharmacol 2011, 82:1126--1133.
47. + and water reabsorption. FASEB J 2007, 21:3717-3726.
48. Orriss IR, Utting JC, Brandao-Burch A, Colston K, Grubb BR, Burnstock G, Arnett TR. Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate. Endocrinology 2007, 148:4208-4216.
49. 4-null mice. Mol Pharmacol 2003, 63:777-783.
50. 6 receptors is a novel mediator of microglial phagocytosis. Nature 2007, 446: 1091-1095.
51. 12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J 2008, 27:3104-3115.
52. 6 nucleotide receptor promotes vascular inflammation in human cell lines and mice. Blood 2011, 117:2548-2555.
53. 6 contributes to airway inflammation and remodeling in asthma. Am J Resp Crit Care Med 2011, 184:215-223.
54. 6 receptor stimulates bone resorption by osteoclasts. Endocrinology 2011, 152:3706-3716.
55. 12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 2003, 112:398-406.
56. 12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 2006, 9:1512-1519.
57. 13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis. Cell Mol Life Sci 2005, 62:2508-2515.
58. 13receptor is critical for reverse cholesterol transport. Hepatology 2010, 52:1477-1483.
59. 13 receptor. Mol Endocrinol 2012, 26:142-152.
60. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001, 11:202-207.
61. 12 receptors with congenital bleeding. Proc Natl Acad Sci U S A 2003, 100:1978-1983.
62. 12 inhibitors. Circulation 2010, 121:171-179.
63. 11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol 2001, 166:7172-7177.
64. 6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res 2006, 98:970-976.
65. Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezon E, Champagne E, Pineau T, Georgeaud V, Walker JE, Tercé F, et al. Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 2003, 421:75-79.